PCN396 CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-TS): ARE ONGOING CLINICAL TRIALS DESIGNED TO MEET EVIDENCE NEEDS OF KEY EUROPEAN HEALTH TECHNOLOGY ASSESSMENT BODIES (HTABS)?
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.591
https://www.valueinhealthjournal.com/article/S1098-3015(19)32969-9/fulltext
Title :
PCN396 CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-TS): ARE ONGOING CLINICAL TRIALS DESIGNED TO MEET EVIDENCE NEEDS OF KEY EUROPEAN HEALTH TECHNOLOGY ASSESSMENT BODIES (HTABS)?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32969-9&doi=10.1016/j.jval.2019.09.591
First page :
Section Title :
Open access? :
No
Section Order :
10506